Advanced Plant Pharmaceuticals enters Phase II human clinical trials for AIDS and names new president.WEST ORANGE, N.J.--(BUSINESS WIRE)--May 28, 1996--Advanced Plant Pharmaceuticals Inc. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. :APPI APPI American Psychiatric Publishing, Inc. APPI American Psychiatric Publishing Inc. APPI American Psychiatric Press, Inc. APPI Atmospheric Pressure Photoionization APPI Advanced Peer-to-Peer Internetworking APPI Advanced Plant Pharmaceuticals Inc. ) announced today that upon the structuring of new management, Morris Moskowitz, as the new president of the company, signed an agreement with the Albert Einstein College of Medicine
The Albert Einstein College of Medicine (AECOM) is a graduate school of Yeshiva University. It is a private medical school located in the Jack and Pearl Resnick Campus of Yeshiva University in the Morris Park of Yeshiva University ("Albert Einstein") located in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , for Albert Einstein to conduct the Phase II human clinical trials on AIDS for the company's plant pharmaceutical product known as Perthon/Abavca. The clinical trials, which are expected to begin shortly, will be conducted by chief investigator Dr. Aryeh Rubinstein of Albert Einstein. Dr. Rubinstein, recognized as one of the world's leaders in AIDS research, is an internationally renowned immunologist whose achievements include the prestigious Lifetime Award in Immunology, which he received in 1990 together with Drs. Fauci, Gallo and Salk. Perthon/Abavca is the first whole plant pharmaceutical to ever receive IND approval from the Food and Drug Administration. The product is also the first and only whole plant pharmaceutical to reach Phase II human clinical trials for AIDS for an immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. booster -- one that works directly on the immune system by boosting it and thereby strengthening the immune system to deal with the virus or help prevent it from forming. The present treatments work as blockers, which help prolong the development of AIDS in HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. patients and may help to prolong the life of the patient. Successful completion of these trials could lead to Perthon/Abavca becoming the first FDA-approved immune system booster. Perthon/Abavca, which is protected by a series of composition patents as well as a method patent, is the first of several plant pharmaceuticals the company intends to distribute internationally. Advanced Plant Pharmaceuticals, the first company to bring the "natural" world and the "ethical drug" world together, utilizes a unique and proprietary method to achieve the standardized manufacturing of whole plant pharmaceuticals. CONTACT: Advanced Plant Pharmaceuticals, West Orange Morris Moskowitz, president, 914/362-4129 or John Joseph & Associates Lauren MacEachen (investor relations Investor relations The process by which the corporation communicates with its investors. ), 516/747-3354 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion